Clinical trials: Consumer Preference
Vasomotor Rhinitis, Seasonal Allergic Rhinitis
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
This is a randomized, two-way crossover, multicenter study evaluating the consumer preference of Phenylephrine Extended Release Tablets, 30 mg to be taken as one tablet every 12 hours, or Phenylephrine Immediate Release Tablets…
- Trial name
- NCT00976209
- Testing
- Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg, Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg
- Volunteers
- 331 people
- Sponsor
- Bayer
Obesity
Daily Habits & Consumer Preferences Study
The study will use a between-subjects design in a sample of individuals with BMI greater than or equal to 28 from the Los Angeles community (N=330). Participants will be randomly assigned to a weight stigma vs.
- Trial name
- NCT05402137
- Testing
- Weight stigma intervention
- Where
- United States
- Volunteers
- 330 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles